Drugs that contain Methylphenidate
1. Drug name - COTEMPLA XR-ODT
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8840924 | NEOS THERAPS INC | Compositions and methods of making rapidly dissolving ionically masked formulations |
Jun, 2026
(3 years from now) | |
| US9072680 | NEOS THERAPS INC | Compositions comprising methylphenidate complexed with ion-exchange resin particles |
Jun, 2032
(9 years from now) | |
| US9089496 | NEOS THERAPS INC | Compositions comprising methylphenidate complexed with ion-exchange resin particles |
Jun, 2032
(9 years from now) | |
| US11166947 | NEOS THERAPS INC | Effective dosing of a child for the treatment of ADHD with methylphenidate |
Jan, 2038
(15 years from now) | |
Treatment: Treatment of attention deficit hyperactivity disorder (adhd) in pediatric patients
Dosage: TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 8.6MG | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL | Prescription |
| 17.3MG | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL | Prescription |
| 25.9MG | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL | Prescription |
2. Drug name - DAYTRANA
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9668981 | NOVEN PHARMS INC | Device for transdermal administration of drugs including acrylic based polymers |
Oct, 2025
(3 years from now) | |
| US9034370 | NOVEN PHARMS INC | Device for transdermal administration of drugs including acrylic polymers |
Oct, 2025
(3 years from now) | |
| US8632802 | NOVEN PHARMS INC | Device for transdermal administration of drugs including acrylic polymers |
Oct, 2025
(3 years from now) | |
Treatment: Method for transdermally delivering a drug to a user in need thereof
Dosage: FILM, EXTENDED RELEASE;TRANSDERMAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 10MG/9HR (1.1MG/HR) | FILM, EXTENDED RELEASE;TRANSDERMAL | Prescription |
| 15MG/9HR (1.6MG/HR) | FILM, EXTENDED RELEASE;TRANSDERMAL | Prescription |
| 20MG/9HR (2.2MG/HR) | FILM, EXTENDED RELEASE;TRANSDERMAL | Prescription |
| 30MG/9HR (3.3MG/HR) | FILM, EXTENDED RELEASE;TRANSDERMAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.